Integer agrees to $5.7 billion KKR buyout
Integer Holdings (NYSE:ITGR) agreed to a $5.7 billion all-cash acquisition by KKR, giving shareholders $127 for each share.
Todas as matérias desta categoria, das mais recentes às mais antigas.
Integer Holdings (NYSE:ITGR) agreed to a $5.7 billion all-cash acquisition by KKR, giving shareholders $127 for each share.
CNH (NYSE:CNH) announced its second-quarter 2026 financial results, reporting consolidated revenues of $4.80 billion.
Italy's Prysmian has reached an all-cash deal to buy electrical manufacturing company Atkore Inc. Prysmian said it's paying $95 per share in an offer that values the company at an enterprise value of about $3.8 billion. Prysmian CEO Massimo Battaini discusses the deal on "Bloomberg Brief."
Easterly Government Properties (NYSE:DEA) announced its financial results for the second quarter of 2026, reporting a net income of $3.2 million.
American Bitcoin (NASDAQ:ABTC) reported Q2 mining revenue of approximately $67 million, up 8%, after producing 932 Bitcoin.
CNA Financial (NYSE:CNA) reported second-quarter net income of $321 million, or $1.18 per share, up from $299 million a year earlier.
Loews (NYSE:L) reported second-quarter net income of $444 million, or $2.16 per share, up from $391 million.
Federal Reserve Chairman Kevin Warsh is weighing the possibility of changing the frequency of regular policy meetings for the US central bank, according to people familiar with the matter. Alister Bull reports on Bloomberg Television.
BP (NYSE:BP) completed the sale of its Gelsenkirchen refinery and related German businesses to Klesch Group, targeting around $1 billion in lower underlying operating expenditure.
Costamare Bulkers (NYSE:CMDB) reported second-quarter adjusted net income of $9.8 million, or $0.40 per share, on total voyage revenue of $111.6 million.
Boeing (NYSE:BA) delivered Somon Air’s first 737-8, introducing Tajikistan’s first operating 737 MAX and supporting the airline’s network expansion.
Oculis (NASDAQ:OCS) received positive FDA feedback supporting Privosegtor’s development for acute multiple sclerosis relapses, where the company said no neuroprotective therapy is approved.
Tem um segundo para um cookie? 🍪Os cookies essenciais mantêm a Grafa funcionando bem. Alguns opcionais nos ajudam a ver o que está funcionando para melhorarmos. Você tem o controle — pode mudar de ideia quando quiser. Política de cookies · Política de privacidade